A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy

Medical Mycology

Volumn 50, Issue 6, 2012, Pages 649-653

  Yang, Yabo ^a   Hu, Yongxuan ^a   Zhang, Junmin ^a   Li, Xiqing ^a   Lu, Changming ^a   Liang, Yuheng ^a   Xi, Liyan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chromoblastomycosis; Fonsecaea monophora; Photodynamic therapy; Voriconazole

Indexed keywords

AMINOLEVULINIC ACID; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE; DNA FRAGMENT; POTASSIUM HYDROXIDE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; CHROMOMYCOSIS; FONSECAEA; FONSECAEA MONOPHORA; FUNGUS ISOLATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PHOTODYNAMIC THERAPY; ACANTHOSIS; AGRICULTURAL WORKER; CHINA; DNA SEQUENCE; EPIDERMIS; FOLLOW UP; GIANT CELL; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HOSPITAL; HYPERPLASIA; IN VITRO STUDY; MEDICAL HISTORY; MICROSCOPY; MIDDLE AGED; MYCOSIS; NONHUMAN; OUTCOME ASSESSMENT; TREATMENT DURATION;

AMINOLEVULINIC ACID; ANTIFUNGAL AGENTS; ASCOMYCOTA; CHINA; CHROMOBLASTOMYCOSIS; HUMANS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NAPHTHALENES; PHOTOCHEMOTHERAPY; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

FONSECAEA MONOPHORA; FONSECAEA PEDROSOI; FUNGI;

EID: 84863938798     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.655258     Document Type: Article

References (23)

1. Garnica M, Nucci M, Queiroz-Telles F. Diffi cult mycoses of the skin: Advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 2009; 22: 559-563.
2. Queiroz-Telles F, Nucci M, Colombo AL, et al . Mycoses of implantation in Latin America: An overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol 2011; 49: 225-236.
3. Badali H, Gueidan C, Najafzadeh MJ, et al . Biodiversity of the genus Cladophialophora . Stud Myco 2008; 61: 175-191.
4. Queiroz-Telles F, Esterre P, Perez-Blanco M, et al . Chromoblastomycosis: An overview of clinical manifestations, diagnosis and treatment. Med Mycol 2009; 47: 3-15.
5. De Hoog GS, Attili-Angelis D, Vicente VA, et al . Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004; 42: 405-416.
6. Najafzadeh MJ, Sun J, Vicente V, et al . Fonsecaea nubica spp. nov, a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol ; 48: 800-806.
7. Hofmann H, Choi SM, Wilsmann-Theis D, et al . Invasive chromoblastomycosis and sinusitis due to Phialophora verrucosa in a child from northern africa. Mycoses 2005; 48: 456-461.
8. Badali H, Bonifaz A, Barron-Tapia T, et al . Rhinocladiella aquaspersa , proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol 2010; 48: 696-703.
9. Xi L, Sun J, Lu C, et al . Molecular diversity of Fonsecaea ( Chaetothyriales ) causing chromoblastomycosis in southern China. Med Mycol 2009; 47: 27-33.
10. Ameen M. Chromoblastomycosis: Clinical presentation and management. Clin Exp Dermatol 2009; 34: 849-854.
11. Bonifaz A, Paredes-Solis V, Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 2004; 5: 247-254.
12. Criado PR, Careta MF, Valente NY, et al . Extensive long-Standing chromomycosis due to Fonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy. J Dermatol Treat 2011; 22: 167-174
13. Zhang J, Xi L, Lu C, et al . Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: A report of three cases in guangdong, China. Mycoses 2009; 52: 176-181.
14. Najafzadeh MJ, Rezusta A, Cameo MI, et al . Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora . Med Mycol 2010; 48: 390-393.
15. Moan J, Peng Q. An outline of the hundred-year history of PDT. A nticancer Res 2003; 23: 3591-3600.
16. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: Update. Br J Dermatol 2008; 159: 1245-1266.
17. Donnelly RF, McCarron PA, Tunney MM. Antifungal photodynamic therapy. Microbiol Res 2008; 163: 1-12.
18. Lyon JP, de Maria Pedroso ESAC, Moreira LM, et al . Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia 2011; 172: 293-297.
19. Perfect JR, Marr KA, Walsh TJ, et al . Voriconazole treatment for lesscommon, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122-1131.
20. Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, et al . In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Ag Chemother 2010; 54: 1636-1638.
21. Andrade TS, Castro LG, Nunes RS, et al . Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 2004; 47: 216-221.
22. Zhang JM, Xi LY, Zhang H, et al . Synergistic effects of terbinafi ne and itraconazole on clinical isolates of Fonsecaea monophora . Eur J Dermatol 2009; 19: 451-455.
23. Gupta AK, Taborda PR, Sanzovo AD. Alternate week and combination itraconazole and terbinafi ne therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 2002; 40: 529-534.